CH4987655

News alerts, weekly reports and conference planners

Company:

Roche

Drug class:

MEK inhibitor

Related drugs:

BRAF V600	Melanoma	BRAF V600	Melanoma	CH4987655 Sensitive: C3 – Early Trials CH4987655 Sensitive : C3	CH4987655 Sensitive: C3 – Early Trials CH4987655 Sensitive : C3
KRAS mutation	Non Small Cell Lung Cancer	KRAS mutation	Non Small Cell Lung Cancer	CH4987655 Sensitive: C3 – Early Trials CH4987655 Sensitive : C3	CH4987655 Sensitive: C3 – Early Trials CH4987655 Sensitive : C3
NRAS mutation	Melanoma	NRAS mutation	Melanoma	CH4987655 Sensitive: C4 – Case Studies CH4987655 Sensitive : C4	CH4987655 Sensitive: C4 – Case Studies CH4987655 Sensitive : C4

Associations
(3)